Entity Details

Primary name LRP5_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionO75197
EntryNameLRP5_HUMAN
FullNameLow-density lipoprotein receptor-related protein 5
TaxID9606
Evidenceevidence at protein level
Length1615
SequenceStatuscomplete
DateCreated2004-05-10
DateModified2021-06-02

Ontological Relatives

GenesLRP5

GO terms

Show/Hide Table
GOName
GO:0001702 gastrulation with mouth forming second
GO:0002053 positive regulation of mesenchymal cell proliferation
GO:0002076 osteoblast development
GO:0005783 endoplasmic reticulum
GO:0005886 plasma membrane
GO:0006007 glucose catabolic process
GO:0006897 endocytosis
GO:0008203 cholesterol metabolic process
GO:0008217 regulation of blood pressure
GO:0008284 positive regulation of cell population proliferation
GO:0009314 response to radiation
GO:0009952 anterior/posterior pattern specification
GO:0015026 coreceptor activity
GO:0016021 integral component of membrane
GO:0017147 Wnt-protein binding
GO:0033690 positive regulation of osteoblast proliferation
GO:0035019 somatic stem cell population maintenance
GO:0035426 extracellular matrix-cell signaling
GO:0042074 cell migration involved in gastrulation
GO:0042632 cholesterol homeostasis
GO:0042733 embryonic digit morphogenesis
GO:0042813 Wnt-activated receptor activity
GO:0042981 regulation of apoptotic process
GO:0043235 receptor complex
GO:0043434 response to peptide hormone
GO:0045600 positive regulation of fat cell differentiation
GO:0045668 negative regulation of osteoblast differentiation
GO:0045669 positive regulation of osteoblast differentiation
GO:0045840 positive regulation of mitotic nuclear division
GO:0045893 positive regulation of transcription, DNA-templated
GO:0045944 positive regulation of transcription by RNA polymerase II
GO:0046849 bone remodeling
GO:0048539 bone marrow development
GO:0051091 positive regulation of DNA-binding transcription factor activity
GO:0060033 anatomical structure regression
GO:0060042 retina morphogenesis in camera-type eye
GO:0060070 canonical Wnt signaling pathway
GO:0060349 bone morphogenesis
GO:0060444 branching involved in mammary gland duct morphogenesis
GO:0060612 adipose tissue development
GO:0060764 cell-cell signaling involved in mammary gland development
GO:0061178 regulation of insulin secretion involved in cellular response to glucose stimulus
GO:0061304 retinal blood vessel morphogenesis
GO:0071901 negative regulation of protein serine/threonine kinase activity
GO:0071936 coreceptor activity involved in Wnt signaling pathway
GO:0110135 Norrin signaling pathway
GO:1901998 toxin transport
GO:1902262 apoptotic process involved in blood vessel morphogenesis
GO:1904928 coreceptor activity involved in canonical Wnt signaling pathway
GO:1990851 Wnt-Frizzled-LRP5/6 complex
GO:1990909 Wnt signalosome

Subcellular Location

Show/Hide Table
Subcellular Location
Endoplasmic reticulum
Membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR000033 LDLR class B repeatRepeatRepeat
IPR000742 EGF-like domainDomainDomain
IPR002172 Low-density lipoprotein (LDL) receptor class A repeatRepeatRepeat
IPR011042 Six-bladed beta-propeller, TolB-likeFamilyHomologous superfamily
IPR017049 Low density lipoprotein receptor-related protein 5/6FamilyFamily
IPR023415 Low-density lipoprotein (LDL) receptor class A, conserved siteSiteConserved site
IPR036055 LDL receptor-like superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
607636 OMIMVan Buchem disease 2 (VBCH2)VBCH2 is an autosomal dominant sclerosing bone dysplasia characterized by cranial osteosclerosis, thickened calvaria and cortices of long bones, enlarged mandible and normal serum alkaline phosphatase levels. The disease is caused by variants affecting the gene represented in this entry.
259770 OMIMOsteoporosis-pseudoglioma syndrome (OPPG)A disease characterized by congenital or infancy-onset blindness and severe juvenile-onset osteoporosis and spontaneous fractures. Additional clinical manifestations may include microphthalmos, abnormalities of the iris, lens or vitreous, cataracts, short stature, microcephaly, ligamental laxity, mental retardation and hypotonia. The disease is caused by variants affecting the gene represented in this entry.
617875 OMIMPolycystic liver disease 4 with or without kidney cysts (PCLD4)A form of polycystic liver disease, an autosomal dominant hepatobiliary disease characterized by overgrowth of biliary epithelium and supportive connective tissue, resulting in multiple liver cysts. PCLD4 patients may also develop kidney cysts that usually do not result in clinically significant renal disease. The disease is caused by variants affecting the gene represented in this entry.
607634 OMIMOsteopetrosis, autosomal dominant 1 (OPTA1)A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. OPTA1 is an autosomal dominant form characterized by generalized osteosclerosis most pronounced in the cranial vault. Patients are often asymptomatic, but some suffer from pain and hearing loss. It appears to be the only type of osteopetrosis not associated with an increased fracture rate. The disease is caused by variants affecting the gene represented in this entry.
133780 OMIMVitreoretinopathy, exudative 1 (EVR1)A disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery. In many ways the disease resembles retinopathy of prematurity but there is no evidence of prematurity or small birth weight in the patient history. The disease is caused by variants affecting the gene represented in this entry.
601813 OMIMVitreoretinopathy, exudative 4 (EVR4)A disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery. The disease is caused by variants affecting the gene represented in this entry.
144750 OMIMEndosteal hyperostosis, Worth type (WENHY)An autosomal dominant sclerosing bone dysplasia clinically characterized by elongation of the mandible, increased gonial angle, flattened forehead, and the presence of a slowly enlarging osseous prominence of the hard palate (torus palatinus). Serum calcium, phosphorus and alkaline phosphatase levels are normal. Radiologically, it is characterized by early thickening of the endosteum of long bones, the skull and of the mandible. With advancing age, the trabeculae of the metaphysis become thickened. WENHY becomes clinically and radiologically evident by adolescence, does not cause deformity except in the skull and mandible, and is not associated with bone pain or fracture. Affected patients have normal height, proportion, intelligence and longevity. The disease is caused by variants affecting the gene represented in this entry.
601884 OMIMHigh bone mass trait (HBM)Rare phenotype characterized by exceptionally dense bones. HBM individuals show otherwise a completely normal skeletal structure and no other unusual clinical findings. The disease is caused by variants affecting the gene represented in this entry.
166710 OMIMOsteoporosis (OSTEOP)A systemic skeletal disorder characterized by decreased bone mass and deterioration of bone microarchitecture without alteration in the composition of bone. The result is fragile bones and an increased risk of fractures, even after minimal trauma. Osteoporosis is a chronic condition of multifactorial etiology and is usually clinically silent until a fracture occurs. Disease susceptibility is associated with variants affecting the gene represented in this entry.